eyeforpharma |New!  Decoding Digital Medicine  |  By Adam Chapman  |other ‘efp’ news articles | Philadelphia 10-11th April 2018 & Check out the winners from eyeforpharma Barcelona & AWARDS 2018

New!   Decoding Digital Medicine |  By Adam Chapman  | 19 March 2018

Opening line:

With the approval of the first ‘digital medicine’ last year, a new digital wave is hitting pharma. What does it look like and how transformative is its potential?


New! What Makes a Patient Tick? |  Danielle Barron |  19 March 2018


“Earlier means a lot earlier – not only for development but in the way that we want to support patients in their day to day lives. Engaging with patient organizations is not difficult – but helping their voices be heard by institutions and payers, that is what counts.”  – Jessica Leygues, Head of Patient Associations and Institutional Patient Programs at Celgene


The New Normal |  | 

An interesting article that folks should read

The pharma industry is on the cusp of a new dawn, but what does it look like?”

eyeforpharma Philadelphia 2018

Apr 10, 2018 – Apr 11, 2018, Philadelphia

Be the trusted healthcare partner


 The Pharma Business Model: How to Avoid the Innovators Dilemma  |   Founder and President of Eularis.  |   

“Pharma needs to adopt the business models of tech companies if it is to flourish” – Dr Andree Bates


“The pharma industry is ripe for disruption. In the past, our value was in new, cutting-edge and effective medicines, discovered, developed, manufactured, marketed and sold by pharma. However, pharma companies are no longer alone, and competitors are coming from unexpected sources. For example, Fuji Film was once a rival of Kodak but has now been in the pharma business for a while, with plans for $921m in pharma sales by 2024 and a bigger global push into complex biologics.”


Pharma’s Place in the Digital Space  |  By Adam Chapman |  Nov 24, 2017

“Sanofi’s Chief Data Officer expounds the possibilities of digital and the role of the CDO in this burgeoning landscape”


“Tech companies have the edge over pharma because digital is built into the base of their business models and woven into the fabric of their operations, he says. In pharma, that job falls to the CDO. “Right now, we treat the CDO as an evangelist and glorified cheerleader, but the larger role is around industrializing digital as an operating model.”



April 10th -11th

16th ANNUAL  |  eyeforpharma Philadelphia & AWARDS 2018

Know your patient. Deliver real value.

twitter > #efpphilly 

Check out the winners from eyeforpharma Barcelona & AWARDS 2018


Shared Via:  eyeforpharma  <<< Sign up for the newsletter > Home Page

Are you a patient advocate why not check out how you can pitch in as #PatientVoice eyeforpharma > patient-policy


eyeforpharma logo

Eyeforpharma – Mission statement:

Our mission is to make pharma more open and valued.
The ultimate driver for the pharmaceutical industry’s health is meeting the needs of patients, otherwise it will cease to matter. For healthcare to be as good as it could be, the strength, skills and resources of our industry need to be fully integrated into health outcomes and we need pharma experience at the decision-making table.
We believe the industry must focus on a business model combining service with product, with patients at the center.

Get the latest industry insights in your inbox:


Follow eyeforpharma on Twitter:


Like eyeforpharma on Facebook:


Subscribe to eyeforpharma youtube channel:


Updated 8 June 2018 social links corrected